Mana Obata-Yasuoka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mana Obata-Yasuoka has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
- Hiromi Hamada
Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
6 shared publications Hiromi Hamada
Department of Obstetrics and Gynecology, Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan
3 shared publicationsHiroyuki Yoshikawa
Departments of Obstetrics & Gynecology
3 shared publicationsMiyuki Mayumi
Department of Obstetrics and Gynecology, Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan
3 shared publications- Toyomi Satoh
Department of Obstetrics and Gynecology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
3 shared publications - Atsuo Itakura
Department of Obstetrics and Gynecology, Faculty of Medicine Juntendo University Tokyo Japan
2 shared publications
Latest Publications
- Open Access
- 28 March 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 112
A case of endoscopic endonasal surgery for a tuberculum sellae meningioma resected in the third trimester of pregnancy
Background: Meningiomas are known to be able to grow rapidly during pregnancy. Moreover, tuberculum sellae meningiomas present with progressive visual dysfunction and occasionally require immediate surgical intervention. Here, we report on the intraoperative and perioperative management of a patient with a tuberculum sellae meningioma who underwent endoscopic endonasal surgery (EES) in the third trimester of pregnancy. Case Description: A 43-year-old woman, gravida 1, para 1, presented with rapidly progressive visual impairment of the left eye. Head magnetic resonance imaging revealed a tuberculum sellae meningioma and surgical intervention was planned for after delivery. However, the patient’s visual impairment progressed further during the pregnancy. Collaboration between the obstetricians and neurosurgeons was established, and the tumor was resected through EES in the third trimester of pregnancy. In surgeries performed in the third trimester of pregnancy, preterm delivery is a well-known complication. Therefore, perioperative uterine contraction monitoring and transvaginal ultrasonography were performed. Considering that the risk of postoperative cerebrospinal fluid leak is high in pregnant women, lumbar drainage was used while at the same time considering that the risk of deep venous thrombosis (DVT) was also increased. Perioperative lower limb ultrasonography was performed frequently, and anticoagulation therapy was initiated postoperatively. The patient was discharged on the 12th postoperative day and underwent a full-term delivery at 37 weeks of pregnancy. Conclusion: EES for pregnant women in the third trimester must be done in close collaboration between obstetricians and neurosurgeons to detect preterm delivery and prevent DVT. This collaboration will lead to safe and effective treatment.
- 28 March 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 112
Open AccessA case of endoscopic endonasal surgery for a tuberculum sellae meningioma resected in the third trimester of pregnancy
Background: Meningiomas are known to be able to grow rapidly during pregnancy. Moreover, tuberculum sellae meningiomas present with progressive visual dysfunction and occasionally require immediate surgical intervention. Here, we report on the intraoperative and perioperative management of a patient with a tuberculum sellae meningioma who underwent endoscopic endonasal surgery (EES) in the third trimester of pregnancy. Case Description: A 43-year-old woman, gravida 1, para 1, presented with rapidly progressive visual impairment of the left eye. Head magnetic resonance imaging revealed a tuberculum sellae meningioma and surgical intervention was planned for after delivery. However, the patient’s visual impairment progressed further during the pregnancy. Collaboration between the obstetricians and neurosurgeons was established, and the tumor was resected through EES in the third trimester of pregnancy. In surgeries performed in the third trimester of pregnancy, preterm delivery is a well-known complication. Therefore, perioperative uterine contraction monitoring and transvaginal ultrasonography were performed. Considering that the risk of postoperative cerebrospinal fluid leak is high in pregnant women, lumbar drainage was used while at the same time considering that the risk of deep venous thrombosis (DVT) was also increased. Perioperative lower limb ultrasonography was performed frequently, and anticoagulation therapy was initiated postoperatively. The patient was discharged on the 12th postoperative day and underwent a full-term delivery at 37 weeks of pregnancy. Conclusion: EES for pregnant women in the third trimester must be done in close collaboration between obstetricians and neurosurgeons to detect preterm delivery and prevent DVT. This collaboration will lead to safe and effective treatment.
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Immunology Research
- Vol. 2025 (1) , 8085784
Nucleated Red Blood Cells Secrete Haptoglobin to Induce Immunosuppressive Function in Monocytes
Nucleated red blood cells (NRBCs) are precursors of red blood cells (RBCs), but also possess variety of immunomodulatory effects. However, among the three types of NRBCs, the immunological effects of human CD45− NRBCs remain largely unknown. We have previously shown that cord blood‐derived CD45− NRBCs and adult peripheral blood‐derived monocytes cocultured in a lipopolysaccharide (LPS)‐stimulated indirect coculture system that avoided cell‐to‐cell contact, increase IL‐10 and decrease TNF‐ α secretion, suggesting an immunosuppressive function of CD45− NRBCs via an unknown soluble factor. The peripheral blood of fetuses and neonates has abundant NRBCs and is physiologically polycythemic, which may lead to the peripheral accumulation of toxic plasma‐free hemoglobin. Plasma‐free hemoglobin binds to haptoglobin, forming a haptoglobin–hemoglobin complex, which is processed within monocytes via the CD163− heme oxygenase 1 (HO‐1) axis and secretes IL‐10. Therefore, we hypothesized that NRBCs secrete haptoglobin and induce the immunosuppressive function of monocytes by activating the CD163−HO‐1 axis. We found that immunosuppressive response decreased when the coculture medium was supplemented with an anti‐CD163 blocking antibody or the HO‐1 inhibitor zinc protoporphyrin IX (ZnPP‐IX). Haptoglobin levels in the culture medium containing NRBCs were high and expressed the haptoglobin gene. Thus, CD45− NRBCs secreted haptoglobin and activated the immunosuppressive function of monocytes.
- 1 January 2025
- Published by Wiley in Journal of Immunology Research
- Vol. 2025 (1) , 8085784
Open AccessNucleated Red Blood Cells Secrete Haptoglobin to Induce Immunosuppressive Function in Monocytes
Nucleated red blood cells (NRBCs) are precursors of red blood cells (RBCs), but also possess variety of immunomodulatory effects. However, among the three types of NRBCs, the immunological effects of human CD45− NRBCs remain largely unknown. We have previously shown that cord blood‐derived CD45− NRBCs and adult peripheral blood‐derived monocytes cocultured in a lipopolysaccharide (LPS)‐stimulated indirect coculture system that avoided cell‐to‐cell contact, increase IL‐10 and decrease TNF‐ α secretion, suggesting an immunosuppressive function of CD45− NRBCs via an unknown soluble factor. The peripheral blood of fetuses and neonates has abundant NRBCs and is physiologically polycythemic, which may lead to the peripheral accumulation of toxic plasma‐free hemoglobin. Plasma‐free hemoglobin binds to haptoglobin, forming a haptoglobin–hemoglobin complex, which is processed within monocytes via the CD163− heme oxygenase 1 (HO‐1) axis and secretes IL‐10. Therefore, we hypothesized that NRBCs secrete haptoglobin and induce the immunosuppressive function of monocytes by activating the CD163−HO‐1 axis. We found that immunosuppressive response decreased when the coculture medium was supplemented with an anti‐CD163 blocking antibody or the HO‐1 inhibitor zinc protoporphyrin IX (ZnPP‐IX). Haptoglobin levels in the culture medium containing NRBCs were high and expressed the haptoglobin gene. Thus, CD45− NRBCs secreted haptoglobin and activated the immunosuppressive function of monocytes.
- 1 June 2024
- Published by SAGE Publications in Stem Cells and Development
- Vol. 33 (11-12) , 262-275
Extracellular Vesicles Derived from Type 2 Diabetic Mesenchymal Stem Cells Induce Endothelial Mesenchymal Transition under High Glucose Conditions Through the TGFβ/Smad3 Signaling Pathway
Type 2 diabetes mellitus (T2DM) is associated with endothelial dysfunction, which results in delayed wound healing. Mesenchymal stem cells (MSC) play a vital role in supporting endothelial cells (EC) and promoting wound healing via paracrine effects through their secretome-containing extracellular vesicles. We previously reported the impaired wound healing ability of adipose tissue-derived MSC from T2DM donors; however, whether extracellular vesicles isolated from T2DM adipose tissue-derived MSC (dEV) exhibit altered functions in comparison to those derived from healthy donors (nEV) is still unclear. In the present study, we found that nEV induced EC survival and angiogenesis, whereas dEV lost these abilities. In addition, under high glucose conditions, nEV protected EC from endothelial mesenchymal transition (EndMT), whereas dEV significantly induced EndMT by activating the TGF/Smad3 signaling pathway, which impaired the tube formation and in vivo wound healing abilities of EC. Interestingly, the treatment of dEV-internalized EC with nEV rescued the induced EndMT effects. Of note, the internalization of nEV into T2DM-derived adipose tissue-MSC resulted in the production of an altered n-dEV, which inhibited EndMT and supported the survival of T2DM db/db mice from severe wounds. Taken together, our findings suggest the role of dEV in endothelial dysfunction and delayed wound healing in T2DM by the promotion of EndMT. Moreover, nEV treatment can be considered as a promising candidate for cell-free therapy to protect EC in T2DM.
- 1 June 2024
- Published by SAGE Publications in Stem Cells and Development
- Vol. 33 (11-12) , 262-275
Extracellular Vesicles Derived from Type 2 Diabetic Mesenchymal Stem Cells Induce Endothelial Mesenchymal Transition under High Glucose Conditions Through the TGFβ/Smad3 Signaling Pathway
Type 2 diabetes mellitus (T2DM) is associated with endothelial dysfunction, which results in delayed wound healing. Mesenchymal stem cells (MSC) play a vital role in supporting endothelial cells (EC) and promoting wound healing via paracrine effects through their secretome-containing extracellular vesicles. We previously reported the impaired wound healing ability of adipose tissue-derived MSC from T2DM donors; however, whether extracellular vesicles isolated from T2DM adipose tissue-derived MSC (dEV) exhibit altered functions in comparison to those derived from healthy donors (nEV) is still unclear. In the present study, we found that nEV induced EC survival and angiogenesis, whereas dEV lost these abilities. In addition, under high glucose conditions, nEV protected EC from endothelial mesenchymal transition (EndMT), whereas dEV significantly induced EndMT by activating the TGF/Smad3 signaling pathway, which impaired the tube formation and in vivo wound healing abilities of EC. Interestingly, the treatment of dEV-internalized EC with nEV rescued the induced EndMT effects. Of note, the internalization of nEV into T2DM-derived adipose tissue-MSC resulted in the production of an altered n-dEV, which inhibited EndMT and supported the survival of T2DM db/db mice from severe wounds. Taken together, our findings suggest the role of dEV in endothelial dysfunction and delayed wound healing in T2DM by the promotion of EndMT. Moreover, nEV treatment can be considered as a promising candidate for cell-free therapy to protect EC in T2DM.
- Top Cited Papers
- 17 October 2022
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 49 (1) , 5-53
Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2020 edition
The 2017 clinical guidelines for obstetrical practice by the Japan Society of Obstetrics and Gynecology and the Japan Association of Obstetricians and Gynecologists were revised and published as the 2020 edition (in Japanese). The aim of these guidelines is to present appropriate standard obstetric diagnosis and management procedures that have reached consensus among Japanese obstetricians. The 2020 guidelines include 113 clinical questions and an appendix, followed by answers (CQ&A; originally 112 in the 2017 edition), a discussion, list of references, and some tables and figures presenting common problems and questions encountered in obstetrical practice. Each answer comes with a recommendation level of A, B, or C and has been prepared based principally on evidence or a consensus among Japanese obstetricians in situations where “evidence” is weak or lacking. Answers with a recommendation level of A or B represent current standard care practices in Japan. All 113 CQ&As and the appendix are presented here to promote a better understanding of the current standard care practices for pregnant and lactating women in Japan.
- 17 October 2022
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 49 (1) , 5-53
Top Cited PapersGuidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2020 edition
The 2017 clinical guidelines for obstetrical practice by the Japan Society of Obstetrics and Gynecology and the Japan Association of Obstetricians and Gynecologists were revised and published as the 2020 edition (in Japanese). The aim of these guidelines is to present appropriate standard obstetric diagnosis and management procedures that have reached consensus among Japanese obstetricians. The 2020 guidelines include 113 clinical questions and an appendix, followed by answers (CQ&A; originally 112 in the 2017 edition), a discussion, list of references, and some tables and figures presenting common problems and questions encountered in obstetrical practice. Each answer comes with a recommendation level of A, B, or C and has been prepared based principally on evidence or a consensus among Japanese obstetricians in situations where “evidence” is weak or lacking. Answers with a recommendation level of A or B represent current standard care practices in Japan. All 113 CQ&As and the appendix are presented here to promote a better understanding of the current standard care practices for pregnant and lactating women in Japan.
- 22 June 2022
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 48 (9) , 2334-2344
Obstetric venous thromboembolism: Evaluation of prophylactic approach based on risk scores, D‐dimer levels, and ultrasonography findings in a tertiary hospital in Japan
Aim: Pulmonary embolism remains a leading cause of maternal mortality in developed countries despite developments in venous thromboembolism prophylaxis strategies. This study aimed to evaluate the effectiveness of our approach involving risk‐scoring, D‐dimer level assessment, and ultrasonography for obstetric venous thromboembolism.Methods: This retrospective cohort study included women who delivered at 22–41 weeks of gestation in The University of Tsukuba Hospital, Japan between January and December 2020. Venous thromboembolism risk (determined according to Japanese guidelines) and D‐dimer levels were evaluated within 20 weeks of gestation, 30–34 weeks of gestation, and during the pre‐delivery period (36 weeks of gestation or any time before preterm delivery). Compression and color Doppler ultrasonography for lower extremity deep vein thrombosis were performed if D‐dimer levels were ≥3.2 μg/mL (for those undergoing cesarean delivery, 1.0 μg/mL).Results: Of 1026 women, 6 women had deep vein thrombosis during pregnancy and 1 during the puerperium period. Pulmonary embolism was not observed. The D‐dimer screening result was positive for 8 women (2%) within 20 weeks of gestation (deep vein thrombosis was confirmed in 3 of them), 87 women (10%) (no deep vein thrombosis) at 30–34 weeks of gestation, and 367 women (36%) during the pre‐delivery period (asymptomatic deep vein thrombosis in one). Based on the Japanese guidelines, 1%, 11%, 33%, and 55% of women had high, intermediate, low, and no postpartum risk factors, respectively.Conclusions: Our approach appears useful for antenatal venous thromboembolism screening in the first trimester. For postpartum prophylaxis, more cost‐effective strategies are needed.
- 22 June 2022
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 48 (9) , 2334-2344
Obstetric venous thromboembolism: Evaluation of prophylactic approach based on risk scores, D‐dimer levels, and ultrasonography findings in a tertiary hospital in Japan
Aim: Pulmonary embolism remains a leading cause of maternal mortality in developed countries despite developments in venous thromboembolism prophylaxis strategies. This study aimed to evaluate the effectiveness of our approach involving risk‐scoring, D‐dimer level assessment, and ultrasonography for obstetric venous thromboembolism.Methods: This retrospective cohort study included women who delivered at 22–41 weeks of gestation in The University of Tsukuba Hospital, Japan between January and December 2020. Venous thromboembolism risk (determined according to Japanese guidelines) and D‐dimer levels were evaluated within 20 weeks of gestation, 30–34 weeks of gestation, and during the pre‐delivery period (36 weeks of gestation or any time before preterm delivery). Compression and color Doppler ultrasonography for lower extremity deep vein thrombosis were performed if D‐dimer levels were ≥3.2 μg/mL (for those undergoing cesarean delivery, 1.0 μg/mL).Results: Of 1026 women, 6 women had deep vein thrombosis during pregnancy and 1 during the puerperium period. Pulmonary embolism was not observed. The D‐dimer screening result was positive for 8 women (2%) within 20 weeks of gestation (deep vein thrombosis was confirmed in 3 of them), 87 women (10%) (no deep vein thrombosis) at 30–34 weeks of gestation, and 367 women (36%) during the pre‐delivery period (asymptomatic deep vein thrombosis in one). Based on the Japanese guidelines, 1%, 11%, 33%, and 55% of women had high, intermediate, low, and no postpartum risk factors, respectively.Conclusions: Our approach appears useful for antenatal venous thromboembolism screening in the first trimester. For postpartum prophylaxis, more cost‐effective strategies are needed.
- Open Access
- 30 July 2019
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 13 (1) , 1-4
Diagnosis of female 17α-hydroxylase deficiency after gonadectomy: a case report
17α-Hydroxylase deficiency is a recessively inherited autosomal disease caused by mutations in the CYP17A1 gene. It is a rare disease and accounts for approximately 1% of congenital adrenal cortex hyperplasias. Inhibition of 17α-hydroxylase causes low levels of cortisol and high levels of adrenocorticotropic hormone in the blood as well as excessive levels of mineralocorticoids that lead to hypertension and hypokalemia. Usually, the female patients are diagnosed with abnormality of the genitalia or extra genitalia, primary amenorrhea, or hypertension in puberty. We report a case of a 29-year-old woman who had undergone gonadectomy in her childhood due to complete androgen insensitivity syndrome and was diagnosed with 17α-hydroxylase deficiency in adulthood. Our patient was a Japanese female diagnosed with androgen insensitivity syndrome, and both gonadectomy and episioplasty were performed at the age of 11 years at the University of Tsukuba Hospital. Thereafter, she was transferred to our hospital at the age of 21 years for vaginoplasty. At the age of 25 years, she presented with hypertension followed by complicated hypokalemia at the age of 28 years. The captopril loading test and adrenocorticotropic hormone loading test of her adrenal steroidogenesis revealed primary aldosteronism. After sufficient genetic counseling, a genetic test was performed that identified her as having CYP17A1 gene mutation. The differential diagnosis of disorders of sex development can be difficult at a young age without complete expression of the phenotype. However, diagnosis at a later age would change the treatment and prognosis of the disease; therefore, a genetic examination should be considered.
- 30 July 2019
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 13 (1) , 1-4
Open AccessDiagnosis of female 17α-hydroxylase deficiency after gonadectomy: a case report
17α-Hydroxylase deficiency is a recessively inherited autosomal disease caused by mutations in the CYP17A1 gene. It is a rare disease and accounts for approximately 1% of congenital adrenal cortex hyperplasias. Inhibition of 17α-hydroxylase causes low levels of cortisol and high levels of adrenocorticotropic hormone in the blood as well as excessive levels of mineralocorticoids that lead to hypertension and hypokalemia. Usually, the female patients are diagnosed with abnormality of the genitalia or extra genitalia, primary amenorrhea, or hypertension in puberty. We report a case of a 29-year-old woman who had undergone gonadectomy in her childhood due to complete androgen insensitivity syndrome and was diagnosed with 17α-hydroxylase deficiency in adulthood. Our patient was a Japanese female diagnosed with androgen insensitivity syndrome, and both gonadectomy and episioplasty were performed at the age of 11 years at the University of Tsukuba Hospital. Thereafter, she was transferred to our hospital at the age of 21 years for vaginoplasty. At the age of 25 years, she presented with hypertension followed by complicated hypokalemia at the age of 28 years. The captopril loading test and adrenocorticotropic hormone loading test of her adrenal steroidogenesis revealed primary aldosteronism. After sufficient genetic counseling, a genetic test was performed that identified her as having CYP17A1 gene mutation. The differential diagnosis of disorders of sex development can be difficult at a young age without complete expression of the phenotype. However, diagnosis at a later age would change the treatment and prognosis of the disease; therefore, a genetic examination should be considered.
- Open Access
- 25 April 2016
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 95 (9) , 1048-1054
Isolated gestational proteinuria preceding the diagnosis of preeclampsia – an observational study
Introduction: Some pregnant women develop significant proteinuria in the absence of hypertension. However, clinical significance of isolated gestational proteinuria (IGP) is not well understood. This study aimed to determine the prevalence of IGP in singleton pregnancies and the proportion of women with IGP who subsequently developed preeclampsia (IGP‐PE) among all PE cases.Material and methods: This was an observational study of 6819 women with singleton pregnancies at 12 centers, including 938 women with at least once determination of protein‐to‐creatinine ratio (P/Cr). Significant proteinuria in pregnancy (SPIP) was defined as P/Cr (mg/mg) level >0.27. IGP was defined as SPIP in the absence of hypertension. Gestational hypertension (GH) preceding preeclampsia (GH‐PE) was defined as preeclampsia (PE) in which GH preceded SPIP. Simultaneous PE (S‐PE) was defined as PE in which both SPIP and hypertension occurred simultaneously.Results: IGP and PE were diagnosed in 130 (1.9%) and 158 (2.3%) of 6819 women, respectively. Of 130 women with IGP, 32 (25%) progressed to PE and accounted for 20% of all women with PE. Hence, women with IGP had a relative risk of 13.1 (95% CI; 9.2–18.5) for developing PE compared with those without IGP [25% (32/130) vs. 1.9% (126/6689)]. At diagnosis of SPIP, P/Cr levels already exceeded 1.0 more often in women with S‐PE than in those with IGP‐PE [67% (33/49) vs. 44% (14/32), respectively, p = 0.031].Conclusions: IGP is a risk factor for PE, and IGP‐PE accounts for a considerable proportion (20%) of all PE.
- 25 April 2016
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 95 (9) , 1048-1054
Open AccessIsolated gestational proteinuria preceding the diagnosis of preeclampsia – an observational study
Introduction: Some pregnant women develop significant proteinuria in the absence of hypertension. However, clinical significance of isolated gestational proteinuria (IGP) is not well understood. This study aimed to determine the prevalence of IGP in singleton pregnancies and the proportion of women with IGP who subsequently developed preeclampsia (IGP‐PE) among all PE cases.Material and methods: This was an observational study of 6819 women with singleton pregnancies at 12 centers, including 938 women with at least once determination of protein‐to‐creatinine ratio (P/Cr). Significant proteinuria in pregnancy (SPIP) was defined as P/Cr (mg/mg) level >0.27. IGP was defined as SPIP in the absence of hypertension. Gestational hypertension (GH) preceding preeclampsia (GH‐PE) was defined as preeclampsia (PE) in which GH preceded SPIP. Simultaneous PE (S‐PE) was defined as PE in which both SPIP and hypertension occurred simultaneously.Results: IGP and PE were diagnosed in 130 (1.9%) and 158 (2.3%) of 6819 women, respectively. Of 130 women with IGP, 32 (25%) progressed to PE and accounted for 20% of all women with PE. Hence, women with IGP had a relative risk of 13.1 (95% CI; 9.2–18.5) for developing PE compared with those without IGP [25% (32/130) vs. 1.9% (126/6689)]. At diagnosis of SPIP, P/Cr levels already exceeded 1.0 more often in women with S‐PE than in those with IGP‐PE [67% (33/49) vs. 44% (14/32), respectively, p = 0.031].Conclusions: IGP is a risk factor for PE, and IGP‐PE accounts for a considerable proportion (20%) of all PE.
- 1 January 2016
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 44 (5) , 551-556
Higher D-dimer level in the early third trimester predicts the occurrence of postpartum hemorrhage
This study aimed to determine effective predictive factors for primary postpartum hemorrhage (PPH) among clinical blood parameters associated with coagulation and fibrinolysis and demographic characteristics.We retrospectively studied 1032 women who underwent determinations of clinical blood parameters at gestational week (GW) 29–32 and GW 35–37 and gave birth to singleton infants at our hospital between January 2011 and December 2013. PPH was defined as estimated blood loss ≥700 mL. Multivariate logistic regression analyses were used to determine independent risk factors and odds ratios (OR) for PPH.PPH occurred in 104 of 1032 women (10%). Three blood variables, fibrinogen level 2.7 μg/mL (2.03 [1.29–3.19]) at GW 35–37, and three demographic characteristics, maternal age ≥35 years (1.75 [1.15–2.68]), BMI >28.2 kg/mAmong blood parameters, higher D-dimer levels and lower levels of antithrombin activity and fibrinogen in late gestation were independent risk factors for PPH.
- 1 January 2016
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 44 (5) , 551-556
Higher D-dimer level in the early third trimester predicts the occurrence of postpartum hemorrhage
This study aimed to determine effective predictive factors for primary postpartum hemorrhage (PPH) among clinical blood parameters associated with coagulation and fibrinolysis and demographic characteristics.We retrospectively studied 1032 women who underwent determinations of clinical blood parameters at gestational week (GW) 29–32 and GW 35–37 and gave birth to singleton infants at our hospital between January 2011 and December 2013. PPH was defined as estimated blood loss ≥700 mL. Multivariate logistic regression analyses were used to determine independent risk factors and odds ratios (OR) for PPH.PPH occurred in 104 of 1032 women (10%). Three blood variables, fibrinogen level 2.7 μg/mL (2.03 [1.29–3.19]) at GW 35–37, and three demographic characteristics, maternal age ≥35 years (1.75 [1.15–2.68]), BMI >28.2 kg/mAmong blood parameters, higher D-dimer levels and lower levels of antithrombin activity and fibrinogen in late gestation were independent risk factors for PPH.
- 1 February 2014
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 23 (2) , 112-116
Impact of planning of pregnancy in women with epilepsy on seizure control during pregnancy and on maternal and neonatal outcomes
- 1 February 2014
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 23 (2) , 112-116
Impact of planning of pregnancy in women with epilepsy on seizure control during pregnancy and on maternal and neonatal outcomes